English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 98 | Tables: 107 | Pharma & Healthcare
The global Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Rotavirus Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The rotavirus vaccine is a vaccine designed to protect against rotavirus, a highly contagious virus that is the leading cause of severe diarrhea and dehydration in infants and young children worldwide. There are two main types of rotavirus vaccines: the monovalent (covering a single strain) and the multivalent (covering multiple strains) versions. Both vaccines contain live, attenuated (weakened) strains of the virus and are administered orally in liquid form.
The North American market for Rotavirus Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Rotavirus Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Rotavirus Vaccine include Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Rotavirus Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Rotavirus Vaccine. The Rotavirus Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Rotavirus Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Rotavirus Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
GlaxoSmithKline Biologicals
Lanzhou Institute of Biological Products
Bharat Biotech
Serum Institute of India
Segment by Type
Monovalent Vaccine
Multivalent Vaccine
by Application
Government Institution
Private Sector
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Rotavirus Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Rotavirus Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Rotavirus Vaccine by Type
1.2.1 Global Rotavirus Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Monovalent Vaccine
1.2.3 Multivalent Vaccine
1.3 Rotavirus Vaccine by Application
1.3.1 Global Rotavirus Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Rotavirus Vaccine Revenue 2021–2032
1.4.2 Global Rotavirus Vaccine Sales 2021–2032
1.4.3 Global Rotavirus Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Rotavirus Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Rotavirus Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Rotavirus Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Rotavirus Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Rotavirus Vaccine, Date of Entry into the Industry
2.8 Global Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Rotavirus Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Rotavirus Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rotavirus Vaccine Market Scenario by Region
3.1 Global Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Rotavirus Vaccine Sales by Region: 2021–2032
3.2.1 Global Rotavirus Vaccine Sales by Region: 2021–2026
3.2.2 Global Rotavirus Vaccine Sales by Region: 2027–2032
3.3 Global Rotavirus Vaccine Revenue by Region: 2021–2032
3.3.1 Global Rotavirus Vaccine Revenue by Region: 2021–2026
3.3.2 Global Rotavirus Vaccine Revenue by Region: 2027–2032
3.4 North America Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Rotavirus Vaccine Sales by Country (2021–2032)
3.4.3 North America Rotavirus Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Rotavirus Vaccine Sales by Country (2021–2032)
3.5.3 Europe Rotavirus Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Rotavirus Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Rotavirus Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Rotavirus Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Rotavirus Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Rotavirus Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Rotavirus Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rotavirus Vaccine Sales by Type (2021–2032)
4.1.1 Global Rotavirus Vaccine Sales by Type (2021–2026)
4.1.2 Global Rotavirus Vaccine Sales by Type (2027–2032)
4.1.3 Global Rotavirus Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Rotavirus Vaccine Revenue by Type (2021–2032)
4.2.1 Global Rotavirus Vaccine Revenue by Type (2021–2026)
4.2.2 Global Rotavirus Vaccine Revenue by Type (2027–2032)
4.2.3 Global Rotavirus Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Rotavirus Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Rotavirus Vaccine Sales by Application (2021–2032)
5.1.1 Global Rotavirus Vaccine Sales by Application (2021–2026)
5.1.2 Global Rotavirus Vaccine Sales by Application (2027–2032)
5.1.3 Global Rotavirus Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Rotavirus Vaccine Revenue by Application (2021–2032)
5.2.1 Global Rotavirus Vaccine Revenue by Application (2021–2026)
5.2.2 Global Rotavirus Vaccine Revenue by Application (2027–2032)
5.2.3 Global Rotavirus Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Rotavirus Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Rotavirus Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline Biologicals
6.2.1 GlaxoSmithKline Biologicals Company Information
6.2.2 GlaxoSmithKline Biologicals Description and Business Overview
6.2.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.3 Lanzhou Institute of Biological Products
6.3.1 Lanzhou Institute of Biological Products Company Information
6.3.2 Lanzhou Institute of Biological Products Description and Business Overview
6.3.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio
6.3.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.4 Bharat Biotech
6.4.1 Bharat Biotech Company Information
6.4.2 Bharat Biotech Description and Business Overview
6.4.3 Bharat Biotech Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bharat Biotech Rotavirus Vaccine Product Portfolio
6.4.5 Bharat Biotech Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Serum Institute of India Rotavirus Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rotavirus Vaccine Industry Chain Analysis
7.2 Rotavirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rotavirus Vaccine Production Mode & Process Analysis
7.4 Rotavirus Vaccine Sales and Marketing
7.4.1 Rotavirus Vaccine Sales Channels
7.4.2 Rotavirus Vaccine Distributors
7.5 Rotavirus Vaccine Customer Analysis
8 Rotavirus Vaccine Market Dynamics
8.1 Rotavirus Vaccine Industry Trends
8.2 Rotavirus Vaccine Market Drivers
8.3 Rotavirus Vaccine Market Challenges
8.4 Rotavirus Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Rotavirus Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Rotavirus Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Rotavirus Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Rotavirus Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Rotavirus Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Rotavirus Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Rotavirus Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Rotavirus Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rotavirus Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Rotavirus Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Rotavirus Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Rotavirus Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Rotavirus Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Rotavirus Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Rotavirus Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Rotavirus Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Rotavirus Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Rotavirus Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Rotavirus Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Rotavirus Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Rotavirus Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Rotavirus Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Rotavirus Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Rotavirus Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Rotavirus Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Rotavirus Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Rotavirus Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Rotavirus Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Rotavirus Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Rotavirus Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Rotavirus Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Rotavirus Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Rotavirus Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Rotavirus Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Rotavirus Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Rotavirus Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Rotavirus Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Rotavirus Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Rotavirus Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Rotavirus Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Rotavirus Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Rotavirus Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GlaxoSmithKline Biologicals Company Information
Table 76. GlaxoSmithKline Biologicals Description and Business Overview
Table 77. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GlaxoSmithKline Biologicals Rotavirus Vaccine Product
Table 79. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 80. Lanzhou Institute of Biological Products Company Information
Table 81. Lanzhou Institute of Biological Products Description and Business Overview
Table 82. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Lanzhou Institute of Biological Products Rotavirus Vaccine Product
Table 84. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 85. Bharat Biotech Company Information
Table 86. Bharat Biotech Description and Business Overview
Table 87. Bharat Biotech Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bharat Biotech Rotavirus Vaccine Product
Table 89. Bharat Biotech Recent Developments/Updates
Table 90. Serum Institute of India Company Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Serum Institute of India Rotavirus Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Rotavirus Vaccine Distributors List
Table 98. Rotavirus Vaccine Customers List
Table 99. Rotavirus Vaccine Market Trends
Table 100. Rotavirus Vaccine Market Drivers
Table 101. Rotavirus Vaccine Market Challenges
Table 102. Rotavirus Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rotavirus Vaccine
Figure 2. Global Rotavirus Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Rotavirus Vaccine Market Share by Type: 2025 & 2032
Figure 4. Monovalent Vaccine Product Picture
Figure 5. Multivalent Vaccine Product Picture
Figure 6. Global Rotavirus Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Rotavirus Vaccine Market Share by Application: 2025 & 2032
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Global Rotavirus Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Rotavirus Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Rotavirus Vaccine Sales (K Units), 2021–2032
Figure 14. Global Rotavirus Vaccine Average Price (US$/Unit), 2021–2032
Figure 15. Rotavirus Vaccine Report Years Considered
Figure 16. Rotavirus Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Rotavirus Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Rotavirus Vaccine Players: Market Share by Revenue in Rotavirus Vaccine in 2025
Figure 19. Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. United States Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Rotavirus Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Rotavirus Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 42. Latin America Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Rotavirus Vaccine by Type (2021–2032)
Figure 53. Global Revenue Market Share of Rotavirus Vaccine by Type (2021–2032)
Figure 54. Global Rotavirus Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Rotavirus Vaccine by Application (2021–2032)
Figure 56. Global Revenue Market Share of Rotavirus Vaccine by Application (2021–2032)
Figure 57. Global Rotavirus Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 58. Rotavirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
